Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma

This publication has 53 references indexed in Scilit:

• Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade
  World Journal of Hepatology, 2015
• In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing
  JACC, 2014
• 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase
  European Journal of Medicinal Chemistry, 2013
• Hepatitis C Virus-Induced Mitochondrial Dysfunctions
  Viruses, 2013
• Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy.
  2012
• Hepatitis C Virus Upregulates Beclin1 for Induction of Autophagy and Activates mTOR Signaling
  Journal of Virology, 2012
• Circulating levels of VEGF family and their receptors in hepatocellular carcinoma
  Bratislava Medical Journal, 2010
• Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL
  Cell Death & Differentiation, 2009
• The autophagy machinery is required to initiate hepatitis C virus replication
  Proceedings of the National Academy of Sciences, 2009
• Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon α Genes
  Journal of Biological Chemistry, 2001